NuScale Power Faces Securities Fraud Class Action After Major Stock Decline NuScale Power Corporation is embroiled in a class action lawsuit following a significant stock drop linked to alleged misrepresentations related to its ENTRA1 partnership.

NuScale Power Faces Securities Fraud Class Action After Major Stock Decline #United_States #New_York #Bleichmar_Fonti #NuScale_Power #ENTRA1

Willis Lease Finance's Board Under Investigation for Executive Compensation Practices Willis Lease Finance Corporation faces scrutiny as its board, led by Charles F. Willis, IV, is investigated for possible breaches in fiduciary duties related to excessive executive compensation.

Willis Lease Finance's Board Under Investigation for Executive Compensation Practices #United_States #New_York #Bleichmar_Fonti #Willis_Lease_Finance #Charles_Willis_IV

Plug Power Inc. Faces Class Action Lawsuit for Alleged Fraud Following DOE Funding Concerns Recent securities fraud allegations against Plug Power Inc. have surfaced, leading to a significant stock drop. Investors are advised to take action.

Plug Power Inc. Faces Class Action Lawsuit for Alleged Fraud Following DOE Funding Concerns #USA #New_York #Securities_Fraud #Bleichmar_Fonti #Plug_Power

Eos Energy Faces Class Action Lawsuit Over Fraud Allegations Following Significant Stock Decline Eos Energy Enterprises, Inc. is under fire as investors file a class action lawsuit following a 39% drop in stock prices due to alleged fraud.

Eos Energy Faces Class Action Lawsuit Over Fraud Allegations Following Significant Stock Decline #United_States #New_York #Securities_Fraud #Bleichmar_Fonti #Eos_Energy

Proposed Settlement Announced in Talis Biomedical Corporation Securities Class Action Lawsuit Bleichmar Fonti & Auld LLP has proposed a settlement in the Talis Biomedical securities litigation, impacting all investors involved during the IPO period. Hearings are set for March 2025.

Proposed Settlement Announced in Talis Biomedical Corporation Securities Class Action Lawsuit #United_States #San_Francisco #securities_litigation #Talis_Biomedical #Bleichmar_Fonti